NO961654L - 2-(pyrazol-3-yl)karbapenem derivater - Google Patents

2-(pyrazol-3-yl)karbapenem derivater

Info

Publication number
NO961654L
NO961654L NO961654A NO961654A NO961654L NO 961654 L NO961654 L NO 961654L NO 961654 A NO961654 A NO 961654A NO 961654 A NO961654 A NO 961654A NO 961654 L NO961654 L NO 961654L
Authority
NO
Norway
Prior art keywords
optionally substituted
hydrogen
alkyl
formula
pyrazol
Prior art date
Application number
NO961654A
Other languages
English (en)
Norwegian (no)
Other versions
NO961654D0 (no
Inventor
Steven Coulton
Jeremy David Hinks
Eric Hunt
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939322284A external-priority patent/GB9322284D0/en
Priority claimed from GB9410929A external-priority patent/GB9410929D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO961654D0 publication Critical patent/NO961654D0/no
Publication of NO961654L publication Critical patent/NO961654L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO961654A 1993-10-29 1996-04-25 2-(pyrazol-3-yl)karbapenem derivater NO961654L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939322284A GB9322284D0 (en) 1993-10-29 1993-10-29 Novel compounds
GB9410929A GB9410929D0 (en) 1994-06-01 1994-06-01 Novel compounds
PCT/GB1994/002347 WO1995011905A1 (en) 1993-10-29 1994-10-25 2-(pyrazol-3-yl)carbapenem derivatives

Publications (2)

Publication Number Publication Date
NO961654D0 NO961654D0 (no) 1996-04-25
NO961654L true NO961654L (no) 1996-06-11

Family

ID=26303758

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961654A NO961654L (no) 1993-10-29 1996-04-25 2-(pyrazol-3-yl)karbapenem derivater

Country Status (22)

Country Link
US (1) US5612477A (de)
EP (1) EP0725783B1 (de)
JP (1) JP3703146B2 (de)
KR (1) KR960705827A (de)
CN (1) CN1167486A (de)
AP (1) AP9600800A0 (de)
AT (1) ATE229957T1 (de)
AU (1) AU697108B2 (de)
BG (1) BG100551A (de)
BR (1) BR9407889A (de)
CA (1) CA2175054C (de)
CZ (1) CZ122996A3 (de)
DE (1) DE69431919T2 (de)
ES (1) ES2188621T3 (de)
FI (1) FI961817L (de)
HU (1) HUT75519A (de)
NO (1) NO961654L (de)
NZ (1) NZ274878A (de)
OA (1) OA10287A (de)
PL (1) PL314173A1 (de)
SK (1) SK53696A3 (de)
WO (1) WO1995011905A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020147333A1 (en) 1993-10-29 2002-10-10 Smithkline Beecham P.L.C. 2-(pyrazol-3-yl)carbapenem derivatives
WO1996011932A1 (en) * 1994-10-14 1996-04-25 Smithkline Beecham Plc 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
IL118092A0 (en) * 1995-05-03 1996-09-12 Smithkline Beecham Plc Antibacterial compounds their preparation and pharmaceutical compositions containing them
CA2217885A1 (en) * 1995-05-03 1996-11-07 Alfred John Eglington Esters of carbapenems
GB0400329D0 (en) * 2004-01-08 2004-02-11 Glaxo Group Ltd Novel processes
GB0400405D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes
JP2007039383A (ja) * 2005-08-03 2007-02-15 Dainippon Sumitomo Pharma Co Ltd アリールカルバペネム化合物の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
EP0430037A3 (en) * 1989-11-21 1992-05-27 Banyu Pharmaceutical Co., Ltd. Process for producing 2-carbon-substituted carbapenem derivatives
CA2036960A1 (en) * 1990-02-26 1991-08-27 Thomas A. Rano Novel synthesis of carbapenem intermediates
JP3233434B2 (ja) * 1992-04-01 2001-11-26 塩野義製薬株式会社 カルバペネム誘導体

Also Published As

Publication number Publication date
HUT75519A (en) 1997-05-28
NO961654D0 (no) 1996-04-25
ES2188621T3 (es) 2003-07-01
JP3703146B2 (ja) 2005-10-05
DE69431919D1 (de) 2003-01-30
ATE229957T1 (de) 2003-01-15
KR960705827A (ko) 1996-11-08
FI961817A7 (fi) 1996-06-28
OA10287A (en) 1997-10-07
WO1995011905A1 (en) 1995-05-04
PL314173A1 (en) 1996-08-19
AU697108B2 (en) 1998-09-24
JPH09504285A (ja) 1997-04-28
FI961817L (fi) 1996-06-28
AU7997594A (en) 1995-05-22
FI961817A0 (fi) 1996-04-29
EP0725783B1 (de) 2002-12-18
AP9600800A0 (en) 1996-04-30
NZ274878A (en) 1998-02-26
BG100551A (bg) 1997-01-31
US5612477A (en) 1997-03-18
SK53696A3 (en) 1996-10-02
CN1167486A (zh) 1997-12-10
DE69431919T2 (de) 2003-11-13
EP0725783A1 (de) 1996-08-14
CZ122996A3 (en) 1996-10-16
HU9601097D0 (en) 1996-07-29
CA2175054A1 (en) 1995-05-04
CA2175054C (en) 2005-07-12
BR9407889A (pt) 1996-10-29

Similar Documents

Publication Publication Date Title
CA2039056A1 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
NO159656C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive karbapenemderivater.
HUP0104816A2 (hu) 3-Azabiciklo[3.1.0]hexán-származékok mint ópiát receptor ligandumok és eljárás előállításukra
IE45015L (en) Cephalosporin derivatives.
DK175689D0 (da) 4-acylcephemsulfon- eller 3-acylpenamsulfonforbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
AU675695B2 (en) Cephalosporin derivatives
HU9300110D0 (en) Method for producing aryl-cycloalkyl derivatives and medical preparatives containing them as active substance
EP0905255A3 (de) Verfahren zur Herstellung von pharmazeutisch aktiven Thiazolidin oder Oxazolidin Verbindungen unter Verwendung einer Hefe-Reduktase
NO961654L (no) 2-(pyrazol-3-yl)karbapenem derivater
AU8824391A (en) New guanidine compounds, process for preparing these and pharmaceutical compositions containing them
EP1180520A4 (de) Heterocyclische carbonsäurederivate
IE780145L (en) Meta-sulphonamido-benzamides
IE790630L (en) 2, 6-dialkoxybenzamido-pyrrolidines.
ES2056860T3 (es) Derivados de n-((2-oxopirrolidin-1-il)-acetil)piperazina y medicamento contra la demencia senil.
AU1312292A (en) New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators
ES442217A1 (es) Procedimiento para la obtencion de derivados cefem.
NO913644L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
AU570541B2 (en) Pharmaceutically active piperidine derivatives
CA1268183A (en) INTERMEDIATES OF PHOSPHORANE USED IN THE PREPARATION OF ANTIBIOTIC PENEMS
CA2490152A1 (en) Oxazole derivatives and their use as insulin sensitizers
FI893570A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
AU5044679A (en) Clavulanic acid derivatives
NO934881L (no) Benzotiazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application